Guam

Guam

NO
Registered Patient Population
0%
of Total Population Represented by Patients
N/A
Average Price Per 1/8
N/A
Average Price Per Gram Cannabis Oil
0
Total Medical Retail Locations Currently in Operation
N/A
Ratio of Patients to Retail Location
Patient Rights and Civil Protection 78/100   
Arrest Protection 40/40
Affirmative Defense 15/15
Parental Rights Protections 9/10
DUI Protections 0/5
Employment Protections 0/5
Explicit Privacy Standards 7/7
Housing Protections 0/5
Does Not Create New Criminal Penalties for Patients 4/5
Organ Transplants 0/5
Reciprocity 3/3
Access to Medicine 78/100   
Allows Distribution Programs 27/40
– Allows Access to Dried Flowers 15/15
– Allows Delivery 0/5
– No Sales Tax or Reasonable Sales Tax 3/5
– Allows for a Reasonable Number of Dispensaries 5/5
– Does Not Require Vertical Integration 2/2
– Ownership/Employment Restrictions 0/2
– Provisions for Labor Standards 0/2
– Environmental Impact Regulations 0/2
– Choice of Dispensary Without Restrictions 2/2
Noncommercial Cultivation 15/20
– Personal Cultivation 15/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 10/10
Does not Impose Bans or Limits on THC 10/10
Does not Impose Bans on CBD 10/10
Local Bans/Zoning 6/10
Comprehensive Qualifying Conditions 50/50
Adding New Conditions 10/10
– Law/Regulations Allow for New Conditions 5/5
– System Works for Adding New Conditions 5/5
Reasonable Access for Minors 8/10
Reasonable Caregiver Background Checks 2/4
Number of Caregivers 2/2
Patient/Practitioner-Focused Task Force or Advisory Board 2/2
Reasonable Fees (Patients and Caregivers) 7/10
Allows Multiple-Year Registrations 0/2
Reasonable Physician Requirements 5/5
Does Not Classify Cannabis as a Medicine of Last Resort 5/5
Functionality 57/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 30/50
No Significant Administrative or Supply Problems 7/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 9/10
Reasonable Possession Limits 4/5
Reasonable Purchase Limits 4/5
Allows Patients to Medicate Where They Choose 3/5
Covered by Insurance/State Health Aid 0/3
Financial Hardship (Fee Waivers/Discount Medicine) 0/7
Consumer Safety and Provider Requirements 64.18/100   
Dispensing 15.09/25
Staff Training 0/5
Standard Operating Procedures 3.75/5
– Facility Sanitary Conditions 0/1.25
– Storage Protocols 1.25/1.25
– Reasonable Security Protocols 1.25/1.25
– Inventory Control 1.25/1.25
Recall Protocol and Adverse Event Reporting 3/5
Product Labeling 5/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 1.67/1.67
– Potency/Compound Identification 1.67/1.67
Required Testing 3.34/5
– Active Compound Identification 1.67/1.67
– Contaminants 0/1.67
– Potency 1.67/1.67
Grow/Cultivation 13.09/25
Staff Training 0/5
Standard Operating Procedures 2.84/5
– Facility and Equipment Sanitary Conditions 0.71/0.71
– Workforce Safety Protocols 0/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0.71/0.71
– Reasonable Security Protocols 0.71/0.71
– Batch and Lot Tracking 0.71/0.71
– Disposal/Waste 0/0.71
– Water Management 0/0.71
Pesticide Guidance 3.5/5
– Pesticide Guidance 2.5/2.5
– Pesticide Labeling 1/2.5
Required Testing 3.75/5
– Active Ingredient Identification 1.25/1.25
– Contaminants 1.25/1.25
– Potency 1.25/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 3/5
Manufacturing 16/25
Staff Training 0/5
Standard Operating Procedures 4/5
– Facility and Equipment Sanitary Conditions 1/1
– Workforce Safety Protocols 0/1
– Storage Protocols 1/1
– Reasonable Security Protocols 1/1
– Batch and Lot Tracking 1/1
Product Labeling 5/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 1.67/1.67
– Potency and Compound Information 1.67/1.67
Required Testing 4/5
– Active Ingredient Identification 1/1
– Contaminants 1/1
– Potency 1/1
– Shelf Life Testing 0/1
– Sample Retention 1/1
Recall Protocol and Adverse Event Reporting 3/5
Laboratory Operations 20/25
Staff Training 5/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 5/5
Independent or Third Party 5/5
Standard Operating Procedures and Protocols 5/5
– Equipment and Instrument Calibration 0.83/0.83
– Sample Tracking 0.83/0.83
– Facility and Equipment Sanitary Conditions 0.83/0.83
– Disposal/Waste 0.83/0.83
– Storage Protocols 0.83/0.83
– Workforce Safety Protocols 0.83/0.83
Covid Response 0/20   
Delivery Available? 0/6
Curbside Pickup Available? 0/2
Medical Cannabis Essential? 0/7
Telemedicine Available? 0/5
Excerpted from ASA's 2020 State of the States Report.

In This Section

The State of Medical Marijuana in Guam

The State of Medical Marijuana in Guam